Data di Pubblicazione:
2017
Citazione:
Trial of Tocilizumab in Giant-Cell Arteritis / Stone, John H; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Schett, Georg; Schulze Koops, Hendrik; Spiera, Robert; Unizony, Sebastian H; Collinson, Neil. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 377:4(2017), pp. 317-328. [10.1056/NEJMoa1613849]
Abstract:
Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolonged use of glucocorticoids is associated with side effects. The effect of the interleukin-6 receptor alpha inhibitor tocilizumab on the rates of relapse during glucocorticoid tapering was studied in patients with giant-cell arteritis.
Tipologia CRIS:
Articolo su rivista
Keywords:
Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Injections, Subcutaneous; Male; Middle Aged; Prednisone; Receptors, Interleukin-6; Remission Induction
Elenco autori:
Stone, John H; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Schett, Georg; Schulze Koops, Hendrik; Spiera, Robert; Unizony, Sebastian H; Collinson, Neil
Link alla scheda completa:
Pubblicato in: